Cargando…
The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties
IL-17A and IL-17F are prominent members of the IL-17 family of cytokines that regulates both innate and adaptive immunity. IL-17A has been implicated in chronic inflammatory and autoimmune diseases, and anti-IL-17A antibodies have shown remarkable clinical efficacy in psoriasis and psoriatic arthrit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566378/ https://www.ncbi.nlm.nih.gov/pubmed/28827714 http://dx.doi.org/10.1038/s41598-017-08360-9 |
_version_ | 1783258538519298048 |
---|---|
author | Goepfert, Arnaud Lehmann, Sylvie Wirth, Emmanuelle Rondeau, Jean-Michel |
author_facet | Goepfert, Arnaud Lehmann, Sylvie Wirth, Emmanuelle Rondeau, Jean-Michel |
author_sort | Goepfert, Arnaud |
collection | PubMed |
description | IL-17A and IL-17F are prominent members of the IL-17 family of cytokines that regulates both innate and adaptive immunity. IL-17A has been implicated in chronic inflammatory and autoimmune diseases, and anti-IL-17A antibodies have shown remarkable clinical efficacy in psoriasis and psoriatic arthritis patients. IL-17A and IL-17F are homodimeric cytokines that can also form the IL-17A/F heterodimer whose precise role in health and disease remains elusive. All three cytokines signal through the assembly of a ternary complex with the IL-17RA and IL-17RC receptors. Here we report the X-ray analysis of the human IL-17A/F heterodimer that reveals a two-faced cytokine closely mimicking IL-17A as well as IL-17F. We also present the crystal structure of its complex with the IL-17RA receptor. Unexpectedly in view of the much higher affinity of this receptor toward IL-17A, we find that IL-17RA is bound to the “F-face” of the heterodimer in the crystal. Using site-directed mutagenesis, we then demonstrate that IL-17RA can also bind to the “A-face” of IL-17A/F with similar affinity. Further, we show that IL-17RC does not discriminate between the two faces of the cytokine heterodimer either, thus enabling the formation of two topologically-distinct heterotrimeric complexes with potentially different signaling properties. |
format | Online Article Text |
id | pubmed-5566378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-55663782017-08-23 The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties Goepfert, Arnaud Lehmann, Sylvie Wirth, Emmanuelle Rondeau, Jean-Michel Sci Rep Article IL-17A and IL-17F are prominent members of the IL-17 family of cytokines that regulates both innate and adaptive immunity. IL-17A has been implicated in chronic inflammatory and autoimmune diseases, and anti-IL-17A antibodies have shown remarkable clinical efficacy in psoriasis and psoriatic arthritis patients. IL-17A and IL-17F are homodimeric cytokines that can also form the IL-17A/F heterodimer whose precise role in health and disease remains elusive. All three cytokines signal through the assembly of a ternary complex with the IL-17RA and IL-17RC receptors. Here we report the X-ray analysis of the human IL-17A/F heterodimer that reveals a two-faced cytokine closely mimicking IL-17A as well as IL-17F. We also present the crystal structure of its complex with the IL-17RA receptor. Unexpectedly in view of the much higher affinity of this receptor toward IL-17A, we find that IL-17RA is bound to the “F-face” of the heterodimer in the crystal. Using site-directed mutagenesis, we then demonstrate that IL-17RA can also bind to the “A-face” of IL-17A/F with similar affinity. Further, we show that IL-17RC does not discriminate between the two faces of the cytokine heterodimer either, thus enabling the formation of two topologically-distinct heterotrimeric complexes with potentially different signaling properties. Nature Publishing Group UK 2017-08-21 /pmc/articles/PMC5566378/ /pubmed/28827714 http://dx.doi.org/10.1038/s41598-017-08360-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Goepfert, Arnaud Lehmann, Sylvie Wirth, Emmanuelle Rondeau, Jean-Michel The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties |
title | The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties |
title_full | The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties |
title_fullStr | The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties |
title_full_unstemmed | The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties |
title_short | The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties |
title_sort | human il-17a/f heterodimer: a two-faced cytokine with unique receptor recognition properties |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566378/ https://www.ncbi.nlm.nih.gov/pubmed/28827714 http://dx.doi.org/10.1038/s41598-017-08360-9 |
work_keys_str_mv | AT goepfertarnaud thehumanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties AT lehmannsylvie thehumanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties AT wirthemmanuelle thehumanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties AT rondeaujeanmichel thehumanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties AT goepfertarnaud humanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties AT lehmannsylvie humanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties AT wirthemmanuelle humanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties AT rondeaujeanmichel humanil17afheterodimeratwofacedcytokinewithuniquereceptorrecognitionproperties |